Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with AlectinibEmily Miao, Luke Pike, Harper Hubbeling et al.|Lung Cancer|2023Cited by 9
BIOM-01. GENOMIC ALTERATIONS IN ALK FUSION-POSITIVE NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH BRAIN METASTASESJordan Eichholz, Luke Pike, Emily Miao et al.|Neuro-Oncology|2022Cited by 0
Characterization of Central Nervous System&nbsp;Clinico-Genomic Outcomes&nbsp;In&nbsp; <i>ALK</i>-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with AlectinibEmily Miao, Luke Pike, Jordan Eichholz et al.|SSRN Electronic Journal|2022Cited by 0